HomeREGULATORY
REGULATORY

Social Security Council Members Reiterate Opposition to Reference Pricing for LLPs, or LLP-Gx Uniform Prices
(Oct.6.2017)

Members of a key health ministry panel renewed their opposition on October 4 to both of two plans being floated as a way to contain spending for off-patent original drugs called long-listed products (LLPs) - introducing a reference pricing system for LLPs, or slashing LLP prices to the levels of their generics ...
(LOG IN FOR FULL STORY)

News Calendar